Clinical Trial Update: A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating STX-0712 in patients with advanced hematologic malignancies is currently recruiting. The study includes chronic myelomonocyt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelomonocytic Leukemia

Drugs mentioned

• STX-0712

Snippet

Sponsor: Solu Therapeutics, Inc | Conditions: Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia (CMML) | Phase 1 | Status: RECRUITING